We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization.

Science (New York, N.Y.) | Nov 5, 2004

The identity of nicotinic receptor subtypes sufficient to elicit both the acute and chronic effects of nicotine dependence is unknown. We engineered mutant mice with a4 nicotinic subunits containing a single point mutation, Leu9' --> Ala9' in the pore-forming M2 domain, rendering a4* receptors hypersensitive to nicotine. Selective activation of a4* nicotinic acetylcholine receptors with low doses of agonist recapitulates nicotine effects thought to be important in dependence, including reinforcement in response to acute nicotine administration, as well as tolerance and sensitization elicited by chronic nicotine administration. These data indicate that activation of a4* receptors is sufficient for nicotine-induced reward, tolerance, and sensitization.

Pubmed ID: 15528443 RIS Download

Mesh terms: Alkaloids | Animals | Azocines | Brain | Bridged Bicyclo Compounds, Heterocyclic | Calcium | Cells, Cultured | Drug Tolerance | Leucine | Mice | Mice, Inbred C57BL | Motor Activity | Neurons | Nicotine | Point Mutation | Pyridines | Quinolizines | Receptors, Nicotinic | Reward | Serine | Tobacco Use Disorder | Up-Regulation

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIDA NIH HHS, Id: DA-15663
  • Agency: NIDA NIH HHS, Id: DA-3194
  • Agency: NIMH NIH HHS, Id: MH-49716
  • Agency: NINDS NIH HHS, Id: NS-11756

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.